Yongtian Wang

Dr. Yongtian Wang

School of Computer Science, Northwestern Polytechnical University, Xi’an 710072, China
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
Yongtian WangYongtian Wang
Yongtian Wang
XLXinmeng Liu
Xinmeng Liu
YSYewei Shen
Yewei Shen
XSXuerui Song
Xuerui Song
Tao WangTao Wang
Tao Wang
Jiajie PengJiajie Peng
Jiajie Peng
Emerging studies have shown that circular RNAs (circRNAs) are involved in a variety of biological processes and play a key role in disease diagnosing, treating and inferring. Although many methods, including traditional machine learning and deep learning, have been developed to predict associations between circRNAs and diseases, the biological function of circRNAs has not been fully exploited. Some methods have explored disease-related circRNAs based on different views, but how to efficiently use the multi-view data about circRNA is still not well studied. Therefore, we propose a computational model to predict potential circRNA–disease associations based on collaborative learning with circRNA multi-view functional annotations. First, we extract circRNA multi-view functional annotations and build circRNA association networks, respectively, to enable effective network fusion. Then, a collaborative deep learning framework for multi-view information is designed to get circRNA multi-source information features, which can make full use of the internal relationship among circRNA multi-view information. We build a network consisting of circRNAs and diseases by their functional similarity and extract the consistency description information of circRNAs and diseases. Last, we predict potential associations between circRNAs and diseases based on graph auto encoder. Our computational model has better performance in predicting candidate disease-related circRNAs than the existing ones. Furthermore, it shows the high practicability of the method that we use several common diseases as case studies to find some unknown circRNAs related to them. The experiments show that CLCDA can efficiently predict disease-related circRNAs and are helpful for the diagnosis and treatment of human disease.

6 June 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
Yongtian WangYongtian Wang
Yongtian Wang
YSYewei Shen
Yewei Shen
JLJiahao Li
Jiahao Li
Tao WangTao Wang
Tao Wang
Jiajie PengJiajie Peng
Jiajie Peng
XSXuequn Shang
Xuequn Shang
Analyzing RNA secondary structures plays a crucial role in elucidating the functional mechanisms of RNA. Despite advances in RNA structure determination, these methods are low throughout and resource-intensive. While machine learning-based models have achieved remarkable performance in terms of prediction accuracy, challenges such as data scarcity and overfitting remain common. Here, we introduce a phased learning strategy that integrates RNA sequence and structural context information to mitigate the risk of overfitting and employs pairing constraints to train the model on folding scores. This approach effectively addresses both local and long-range nucleotide interactions, substantially improving the robustness of RNA secondary structure predictions. Our comprehensive analysis across multiple benchmarking datasets demonstrated that the performance of our model (DSRNAFold) was superior to that of existing methods, especially in pseudoknot recognition and chemical mapping activity prediction, where our approach showed positive performance.

10 September 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
Yongtian WangYongtian Wang
Yongtian Wang
WSWenkai Shen
Wenkai Shen
YSYewei Shen
Yewei Shen
SFShang Feng
Shang Feng
TWTao Wang
Tao Wang
Jiajie PengJiajie Peng
Jiajie Peng
Circular RNAs (circRNAs) play a crucial role in gene regulation and have been implicated in the development of drug resistance in cancer, representing a significant challenge in oncological therapeutics. Despite advancements in computational models predicting RNA-drug interactions, existing frameworks often overlook the complex interplay between circRNAs, drug mechanisms, and disease contexts. This study aims to bridge this gap by introducing a novel computational model, circRDRP, that enhances prediction accuracy by integrating disease-specific contexts into the analysis of circRNA-drug interactions. It employs a hybrid graph neural network that combines features from Graph Attention Networks (GAT) and Graph Convolutional Networks (GCN) in a two-layer structure, with further enhancement through convolutional neural networks. This approach allows for sophisticated feature extraction from integrated networks of circRNAs, drugs, and diseases. Our results demonstrate that the circRDRP model outperforms existing models in predicting drug resistance, showing significant improvements in accuracy, precision, and recall. Specifically, the model shows robust predictive capability in case studies involving major anticancer drugs such as Cisplatin and Methotrexate, indicating its potential utility in precision medicine. In conclusion, circRDRP offers a powerful tool for understanding and predicting drug resistance mediated by circRNAs, with implications for designing more effective cancer therapies.

20 February 2026 in BMC Biology
Verified
Journal Article
Open access
PDF file
Yongtian WangYongtian Wang
Yongtian Wang
ZWZhiyuan Wang
Zhiyuan Wang
TWTao Wang
Tao Wang
JHJialu Hu
Jialu Hu
ZYZhuhong You
Zhuhong You
Jiajie PengJiajie Peng
Jiajie Peng
Background: Long noncoding RNAs (lncRNAs) have emerged as crucial regulators in the pathogenesis of complex human diseases. Despite significant advances, identifying disease-associated lncRNAs remains challenging due to the vast noncoding transcriptome and the complexity of lncRNA interaction networks. Results: We propose HiGLDP, a computational framework for predicting lncRNA-disease associations through the integration of multi-omic data and advanced graph neural network techniques. HiGLDP constructs comprehensive similarity networks for lncRNAs and diseases using genomic, transcriptomic, and proteomic information, which are refined using random walk with restart (RWR) and denoising autoencoders (DAE). The bipartite lncRNA-disease association network is transformed into an interconnected graph with relationship nodes, while an association feature graph is constructed based on cosine similarity. A hybrid graph neural network architecture combining graph convolutional networks (GCN) and graph attention networks (GAT) is employed to capture both local and global graph structures, followed by a multilayer perceptron (MLP) for association classification. Comprehensive evaluations demonstrate that HiGLDP achieves superior predictive performance, accuracy, and robustness compared with existing methods. Case studies further validate its effectiveness in identifying novel lncRNA-disease associations. Conclusions: HiGLDP provides a robust and interpretable computational framework for lncRNA-disease association prediction. By integrating multi-omic information with hybrid graph learning, it offers valuable insights into lncRNA-disease interactions and represents a meaningful advancement in predictive modeling in this field.

5 March 2025 in Small Methods
Verified
Journal Article
Closed access
Yongtian WangYongtian Wang
Yongtian Wang
JLJintian Luo
Jintian Luo
SJShaoqing Jiao
Shaoqing Jiao
XXXiaohan Xie
Xiaohan Xie
TWTao Wang
Tao Wang
Jiajie PengJiajie Peng
Jiajie Peng

6 April 2022 in BMC Genomics
Verified
Journal Article
Open access
PDF file
Yongtian WangYongtian Wang
Yongtian Wang
LJLiran Juan
Liran Juan
Jiajie PengJiajie Peng
Jiajie Peng
Tao WangTao Wang
Tao Wang
TZTianyi Zang
Tianyi Zang
YWYadong Wang
Yadong Wang
Background: In biological systems, metabolomics can not only contribute to the discovery of metabolic signatures for disease diagnosis, but is very helpful to illustrate the underlying molecular disease-causing mechanism. Therefore, identification of disease-related metabolites is of great significance for comprehensively understanding the pathogenesis of diseases and improving clinical medicine. Results: In the paper, we propose a disease and literature driven metabolism prediction model (DLMPM) to identify the potential associations between metabolites and diseases based on latent factor model. We build the disease glossary with disease terms from different databases and an association matrix based on the mapping between diseases and metabolites. The similarity of diseases and metabolites is used to complete the association matrix. Finally, we predict potential associations between metabolites and diseases based on the matrix decomposition method. In total, 1,406 direct associations between diseases and metabolites are found. There are 119,206 unknown associations between diseases and metabolites predicted with a coverage rate of 80.88%. Subsequently, we extract training sets and testing sets based on data increment from the database of disease-related metabolites and assess the performance of DLMPM on 19 diseases. As a result, DLMPM is proven to be successful in predicting potential metabolic signatures for human diseases with an average AUC value of 82.33%. Conclusion: In this paper, a computational model is proposed for exploring metabolite-disease pairs and has good performance in predicting potential metabolites related to diseases through adequate validation. The results show that DLMPM has a better performance in prioritizing candidate diseases-related metabolites compared with the previous methods and would be helpful for researchers to reveal more information about human diseases.